NRX Pharmaceuticals, Inc. (NRXP) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
BitDigital (NRXP) Q1 2026: WhiteFiber Stake Hits $322M as Mining Shrinks to 13% of Revenue
May 18, 2026
-
NRXP Q4 2025: R&D Spend Down $2.4M as Three Drug Approval Paths Converge
March 24, 2026
-
NRXP Q3 2025: Hope Clinics Pipeline Adds $20M Potential, Accelerating Neuropsychiatry Shift
November 17, 2025
-
NRXP Q2 2025: Operating Loss Down 47% as Regulatory Milestones Unlock Ketamine Market Upside
August 20, 2025